Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Kevin E Lofton is Director at Medtronic. OQRO lists 5 transactions filed with the SEC under this name, the latest on Oct 21, 2026, each linked to the official Form 4.
Director
Disclosures on record
5
Companies involved
2
MedtronicMDT
3 disclosures · Apr 2026 – Oct 2026
Oct 15, 2026182disclosed Oct 21
DetailsOfficial recordApr 27, 20262,111disclosed Apr 30
DetailsOfficial recordApr 28, 2026207disclosed Apr 30
DetailsOfficial recordMinimed GroupMMED
2 disclosures · Oct 2026
Oct 15, 2026836disclosed Oct 19
DetailsOfficial recordOct 9, 202612Kdisclosed Oct 13
DetailsOfficial recordAs of the latest filing on , Kevin E Lofton reported holding 9,977 shares of Medtronic (MDT), worth about $1.03M at the last close of $103 (Nov 16, 2026). Holdings are also on file at Minimed Group (MMED); together they are worth about $1.78M.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Medtronic MDT | 9,977 | 9,977 direct | $103 | $1.03M | Oct 15, 2026 |
| Minimed Group MMED | 40,409 | 40K direct | $19 | $754K | Oct 15, 2026 |
Is this Kevin E Lofton’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Kevin E Lofton has no open-market purchase on record since 2016. Sales in 1 of the 11 years since 2016.
Kevin E Lofton reported 0 open-market purchases and 1 sale since 2016; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2016 | — | $287K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Oct 15, 2026, Kevin E Lofton reported holding 9,977 shares of Medtronic (MDT). At the last close of $103 on Nov 16, 2026, that is about $1.03M. This is the stake disclosed in filings, not a net worth.
Kevin E Lofton has no open-market purchase on record since 2016. Sales in 1 of the 11 years since 2016.
In SEC filings since 2016: no open-market purchase is on record; the latest open-market sale is from 2016.
Gilead Sciences (GILD), from 2016 to 2016: 0 purchases and 1 sale.
Kevin E Lofton reported 0 open-market purchases and 1 sale here, 2016.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.